←
Zach Steinhart60 posts
Zach Steinhart avatar

Zach Steinhart

@CrisprEh

Postdoc in the @marsonlab @GladstoneInst/@UCSF. Parker Scholar @parkerici. Interested in genomics, CRISPR, cancer immunotherapy, and much more! 🇨🇦

◷ Joined May 2021▧ 12 Photos and videos
Zach Steinhart avatar
Zach Steinhart@CrisprEh·3 Feb 2022

Thrilled to have our recent work from the @marsonlab published in @ScienceMagazine science.org/doi/10.1126/scie…. This was the result of an awesome collaboration between myself and fellow Marson Lab postdoc, @R_Schmidt_ (1/12)

Maya Arce avatar
⟳ Zach Steinhart retweeted
Maya Arce@maya_m_arce·3 Sep 2025

Excited to share that the Arce Lab is launching today at @arcinstitute ! We will explore the mechanisms controlling immune cell function using genomics and biochemistry in an effort to understand immune-mediated diseases. arcinstitute.org/labs/arcela…

Maya Arce avatar
⟳ Zach Steinhart retweeted
Maya Arce@maya_m_arce·11 Dec 2024

Excited to share the latest from the @MarsonLab! An investigation of context-specific gene regulation in T cells, which led to dynamic mechanisms required to control T cell rest and activation. Published today in @Nature thanks to the work of many! nature.com/articles/s41586-0…

Majzner_Lab avatar
⟳ Zach Steinhart retweeted
Majzner_Lab@Majzner_Lab·9 Mar 2023

Happy to share the newest paper from our lab. Led by technician extraordinaire Aidan Tousley (soon to be an MD/PHD student!), this manuscript details our attempts to reimagine the structure of CARs to improve their specificity and efficacy. rdcu.be/c7avS

Justin Eyquem avatar
⟳ Zach Steinhart retweeted
Justin Eyquem@j_eyquem·13 Jan 2023

Thrilled to share the first Eyquem lab paper! Today we report in @CellCellPress evolving the AAV6 capsid to enable efficient engineering of murine T cells. An exciting collab with @asokanduke and led by the brilliants @WilliamNyberg and Jon Ark cell.com/cell/fulltext/S0092… 🧵1/11

Rosmely Hernandez avatar
⟳ Zach Steinhart retweeted
Rosmely Hernandez@RosmelyHdez·25 Feb 2022

I'm very excited to share our review article rdcu.be/cHLHy @NatRevImmunol where we discussed how IL-2 has been engineered since its discovery to improve its in vivo activity and T cell selectivity and drive therapeutic efficacy in the context of autoimmunity and cancer.

Zach Steinhart avatar
Zach Steinhart@CrisprEh·3 Feb 2022

We are super excited about the potential of these methods to discover new targets to incorporate into synthetic circuits for next generation T cell therapies! So many interesting facets of T cell biology to explore with this tech and we are very happy to share our protocols.

Zach Steinhart avatar
Zach Steinhart@CrisprEh·3 Feb 2022

In summary, using paired genome-wide CRISPRa/i screens we comprehensively mapped the functional gene networks regulating IL-2 and IFN-g in human T cells. Arrayed and single-cell follow-up enabled deep investigation of hits, revealing how they affect stimulation-responsive states.

Zach Steinhart avatar
Zach Steinhart@CrisprEh·3 Feb 2022

We found that that these CRISPRa perturbations not only enhanced or repressed overall activation, but steered T cells to different stimulation-responsive states, many of which were marked by the expression of different cytokine or other effector genes.

Post attachment
Zach Steinhart avatar
Zach Steinhart@CrisprEh·3 Feb 2022

However, T cells are heterogenous in nature, so we asked how do these perturbations affect T cell states at the single-cell level? By pairing CRISPRa with single-cell RNA-seq (CRISPRa Perturb-seq) we were able to identify distinct cell states driven by ~70 genome-wide screen hits

Post attachment